BELLUS Health Quote - BLU | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
Canada
TSX
BELLUS Health Inc (BLU) Share Price

BELLUS Health Inc (BLU)

19.48

0.00

( 0.00% )

Updated: 10:00:00

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Current Price

19.48

Bid

19.46

Offer

19.52

Volume

-

0.00 Day's Range 0.00

19.48 52 Week Range 19.48

Previous Close

19.48

Open

-

Last Trade

Last Trade Time

Average Volume (3m)

-

Financial Volume

-

VWAP

-

Annonce boursière - Réservée aux médias et aux investisseurs - GSK mène à terme l'acquisition de BELLUS Santé

Annonce boursière - Réservée aux médias et aux investisseurs - GSK mène à terme l'acquisition de BELLUS...

Stock-exchange announcement - For media and investors only - GSK completes acquisition of BELLUS Health

Stock-exchange announcement - For media and investors only - GSK completes acquisition of BELLUS Health Canada NewsWire LONDON, June 28, 2023...

S&P Dow Jones Indices annonce des modifications à l'indice composé S&P/TSX et à l'indice S&P/TSX 60

S&P Dow Jones Indices annonce des modifications à l'indice composé S&P/TSX et à l'indice S&P/TSX 60 Canada...

S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index and S&P/TSX 60 Index

S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index and S&P/TSX 60 Index Canada NewsWire TORONTO, Sept. 2, 2022...

BELLUS Santé présentera les plus récentes données cliniques de l’essai SOOTHE de phase 2b du BLU‑5937 à la ATS 2022 International Conference

BELLUS Santé inc. (Nasdaq : BLU; TSX : BLU) (« BELLUS Santé » ou la « société »), une société biopharmaceutique au stade clinique qui développe...

BELLUS Health to Participate in Multiple Upcoming Investor Conferences

BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel...

BELLUS Health to Participate in the Cowen & Co. 42nd Annual Health Care Conference

BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	19.48	19.48	19.48	0	0	CS
4	0	0	19.48	19.48	19.48	0	0	CS
12	0	0	19.48	19.48	19.48	0	0	CS
26	0	0	19.48	19.48	19.48	0	0	CS
52	0	0	19.48	19.48	19.48	0	0	CS
156	8.99	85.7006673022	10.49	19.9	8.07	46071	13.23546257	CS
260	6.29	47.6876421531	13.19	19.9	2.7	90567	8.31394857	CS

BLU - Frequently Asked Questions (FAQ)

What is the current BELLUS Health share price?

The current share price of BELLUS Health is $ 19.48

What is the 1 year trading range for BELLUS Health share price?

BELLUS Health has traded in the range of $ 19.48 to $ 19.48 during the past year

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
FTFortune Minerals Limited	$ 0.07 (27.27%)	1.86M
CFFConifex Timber Inc	$ 0.35 (22.81%)	11k
AVLAvalon Advanced Materials Inc	$ 0.03 (20.00%)	154.91k
ESMEuro Sun Mining Inc	$ 0.095 (18.75%)	3.02M
EXNExcellon Resources Inc	$ 0.165 (17.86%)	795.86k
FLNTFlint Corporation	$ 0.02 (-20.00%)	10k
LSPKLifeSpeak Inc	$ 0.17 (-19.05%)	22.5k
APLIAppili Therapeutics Inc	$ 0.025 (-16.67%)	30k
BKIBlack Iron Inc	$ 0.08 (-15.79%)	408.66k
VQSVIQ Solutions Inc	$ 0.165 (-13.16%)	150.75k
BTEBaytex Energy Corp	$ 2.30 (2.68%)	5.73M
BTOB2Gold Corp	$ 4.65 (0.65%)	5.41M
IMGIAMGOLD Corporation	$ 11.25 (8.28%)	5.03M
DSVDiscovery Silver Corp	$ 2.78 (2.58%)	4.2M
CVECenovus Energy Inc	$ 16.15 (2.15%)	4.2M

mik1234

mik1234 4 years ago

it was a good day $$ BLU

Oliverjack

Oliverjack 5 years ago

insider bought 260k worth today monday 13th lol

Bottom Feedr

Bottom Feedr 5 years ago

Massive drop and ceo buys more! Hmmnnnn

Bottom Feedr

Bottom Feedr 5 years ago

Wake up sleepy head time to rock the market!

dalesio_98

dalesio_98 6 years ago

RichardSawars

RichardSawars 6 years ago

TrendTrade2016

TrendTrade2016 7 years ago

BLU.TO hot canadian bio

TrendTrade2016

TrendTrade2016 7 years ago

BLU is a beast!!

TrendTrade2016

TrendTrade2016 7 years ago

The BLU beast!!

TrendTrade2016

TrendTrade2016 7 years ago

put out a call on BLU.TO a monster bio play!!

xr_biotech_consult

xr_biotech_consult 9 years ago

happy to sold nearly 8000 during last days...only 4000 left for sale today.

xr_biotech_consult

xr_biotech_consult 9 years ago

2.99 weeeeEEEE°°

xr_biotech_consult

xr_biotech_consult 9 years ago

what shoud i say? 2.32 !!

xr_biotech_consult

xr_biotech_consult 9 years ago

xr_biotech_consult

xr_biotech_consult 9 years ago

yessss..new high..1.92

xr_biotech_consult

xr_biotech_consult 9 years ago

great Chart.. crushed 1,75 good sign. more will come

xr_biotech_consult

xr_biotech_consult 9 years ago

pivotal Phase 3 trail completed, top line results expected q2, fast track by FDA, rare desease, Long patent protection, Peak sales expected -1b ! ongoing Pipeline with rare deseases.. still great opportunity here

xr_biotech_consult

xr_biotech_consult 9 years ago

xr_biotech_consult

xr_biotech_consult 9 years ago

hrhr here weee goo

xr_biotech_consult

xr_biotech_consult 9 years ago

expected Prices per Patient per year 200-275 Thousand

xr_biotech_consult

xr_biotech_consult 9 years ago

Peak sales expected 600m - 1b
http://www.bellushealth.com/English/investors-and-news/presentations/default.aspx

xr_biotech_consult

xr_biotech_consult 9 years ago

xr_biotech_consult

xr_biotech_consult 10 years ago

will move up again

xr_biotech_consult

xr_biotech_consult 11 years ago

target 2.50 CAD

xr_biotech_consult

xr_biotech_consult 11 years ago

yea hell great, new high hunts new high

xr_biotech_consult

xr_biotech_consult 11 years ago

BLU out in the blue

xr_biotech_consult

xr_biotech_consult 11 years ago

waht did i told u

xr_biotech_consult

xr_biotech_consult 11 years ago

massive breakout will come here

Generative Al Solutions

Accelerate Arbitrage

Canadian National Railway

Centrue Financial

Demesne Resources

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions